Cargando…

The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG

We previously reported interferon gamma secretion by human CD4(+) and CD8(+) T cells in response to recombinant E. coli-expressed Rv1860 protein of Mycobacterium tuberculosis (MTB) as well as protection of guinea pigs against a challenge with virulent MTB following prime-boost immunization with DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Satchidanandam, Vijaya, Kumar, Naveen, Jumani, Rajiv S., Challu, Vijay, Elangovan, Shobha, Khan, Naseem A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055742/
https://www.ncbi.nlm.nih.gov/pubmed/24945624
http://dx.doi.org/10.1371/journal.ppat.1004176
_version_ 1782320717661995008
author Satchidanandam, Vijaya
Kumar, Naveen
Jumani, Rajiv S.
Challu, Vijay
Elangovan, Shobha
Khan, Naseem A.
author_facet Satchidanandam, Vijaya
Kumar, Naveen
Jumani, Rajiv S.
Challu, Vijay
Elangovan, Shobha
Khan, Naseem A.
author_sort Satchidanandam, Vijaya
collection PubMed
description We previously reported interferon gamma secretion by human CD4(+) and CD8(+) T cells in response to recombinant E. coli-expressed Rv1860 protein of Mycobacterium tuberculosis (MTB) as well as protection of guinea pigs against a challenge with virulent MTB following prime-boost immunization with DNA vaccine and poxvirus expressing Rv1860. In contrast, a Statens Serum Institute Mycobacterium bovis BCG (BCG-SSI) recombinant expressing MTB Rv1860 (BCG-TB1860) showed loss of protective ability compared to the parent BCG strain expressing the control GFP protein (BCG-GFP). Since Rv1860 is a secreted mannosylated protein of MTB and BCG, we investigated the effect of BCG-TB1860 on innate immunity. Relative to BCG-GFP, BCG-TB1860 effected a significant near total reduction both in secretion of cytokines IL-2, IL-12p40, IL-12p70, TNF-α, IL-6 and IL-10, and up regulation of co-stimulatory molecules MHC-II, CD40, CD54, CD80 and CD86 by infected bone marrow derived dendritic cells (BMDC), while leaving secreted levels of TGF-β unchanged. These effects were mimicked by BCG-TB1860His which carried a 6-Histidine tag at the C-terminus of Rv1860, killed sonicated preparations of BCG-TB1860 and purified H37Rv-derived Rv1860 glycoprotein added to BCG-GFP, but not by E. coli-expressed recombinant Rv1860. Most importantly, BMDC exposed to BCG-TB1860 failed to polarize allogeneic as well as syngeneic T cells to secrete IFN-γ and IL-17 relative to BCG-GFP. Splenocytes from mice infected with BCG-SSI showed significantly less proliferation and secretion of IL-2, IFN-γ and IL-17, but secreted higher levels of IL-10 in response to in vitro restimulation with BCG-TB1860 compared to BCG-GFP. Spleens from mice infected with BCG-TB1860 also harboured significantly fewer DC expressing MHC-II, IL-12, IL-2 and TNF-α compared to mice infected with BCG-GFP. Glycoproteins of MTB, through their deleterious effects on DC may thus contribute to suppress the generation of a TH1- and TH17-dominated adaptive immune response that is vital for protection against tuberculosis.
format Online
Article
Text
id pubmed-4055742
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40557422014-06-18 The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG Satchidanandam, Vijaya Kumar, Naveen Jumani, Rajiv S. Challu, Vijay Elangovan, Shobha Khan, Naseem A. PLoS Pathog Research Article We previously reported interferon gamma secretion by human CD4(+) and CD8(+) T cells in response to recombinant E. coli-expressed Rv1860 protein of Mycobacterium tuberculosis (MTB) as well as protection of guinea pigs against a challenge with virulent MTB following prime-boost immunization with DNA vaccine and poxvirus expressing Rv1860. In contrast, a Statens Serum Institute Mycobacterium bovis BCG (BCG-SSI) recombinant expressing MTB Rv1860 (BCG-TB1860) showed loss of protective ability compared to the parent BCG strain expressing the control GFP protein (BCG-GFP). Since Rv1860 is a secreted mannosylated protein of MTB and BCG, we investigated the effect of BCG-TB1860 on innate immunity. Relative to BCG-GFP, BCG-TB1860 effected a significant near total reduction both in secretion of cytokines IL-2, IL-12p40, IL-12p70, TNF-α, IL-6 and IL-10, and up regulation of co-stimulatory molecules MHC-II, CD40, CD54, CD80 and CD86 by infected bone marrow derived dendritic cells (BMDC), while leaving secreted levels of TGF-β unchanged. These effects were mimicked by BCG-TB1860His which carried a 6-Histidine tag at the C-terminus of Rv1860, killed sonicated preparations of BCG-TB1860 and purified H37Rv-derived Rv1860 glycoprotein added to BCG-GFP, but not by E. coli-expressed recombinant Rv1860. Most importantly, BMDC exposed to BCG-TB1860 failed to polarize allogeneic as well as syngeneic T cells to secrete IFN-γ and IL-17 relative to BCG-GFP. Splenocytes from mice infected with BCG-SSI showed significantly less proliferation and secretion of IL-2, IFN-γ and IL-17, but secreted higher levels of IL-10 in response to in vitro restimulation with BCG-TB1860 compared to BCG-GFP. Spleens from mice infected with BCG-TB1860 also harboured significantly fewer DC expressing MHC-II, IL-12, IL-2 and TNF-α compared to mice infected with BCG-GFP. Glycoproteins of MTB, through their deleterious effects on DC may thus contribute to suppress the generation of a TH1- and TH17-dominated adaptive immune response that is vital for protection against tuberculosis. Public Library of Science 2014-06-12 /pmc/articles/PMC4055742/ /pubmed/24945624 http://dx.doi.org/10.1371/journal.ppat.1004176 Text en © 2014 Satchidanandam et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Satchidanandam, Vijaya
Kumar, Naveen
Jumani, Rajiv S.
Challu, Vijay
Elangovan, Shobha
Khan, Naseem A.
The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG
title The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG
title_full The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG
title_fullStr The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG
title_full_unstemmed The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG
title_short The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG
title_sort glycosylated rv1860 protein of mycobacterium tuberculosis inhibits dendritic cell mediated th1 and th17 polarization of t cells and abrogates protective immunity conferred by bcg
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055742/
https://www.ncbi.nlm.nih.gov/pubmed/24945624
http://dx.doi.org/10.1371/journal.ppat.1004176
work_keys_str_mv AT satchidanandamvijaya theglycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg
AT kumarnaveen theglycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg
AT jumanirajivs theglycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg
AT challuvijay theglycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg
AT elangovanshobha theglycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg
AT khannaseema theglycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg
AT satchidanandamvijaya glycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg
AT kumarnaveen glycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg
AT jumanirajivs glycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg
AT challuvijay glycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg
AT elangovanshobha glycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg
AT khannaseema glycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg